Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung Cancer

Abstract excerpt

PURPOSE: It is a critical challenge to determine the risk of recurrence in early stage non-small cell lung cancer (NSCLC) patients. Accurate gene expression signatures are needed to classify patients into high- and low-risk groups to improve the selection of patients for adjuvant therapy. EXPERIMENTAL DESIGN: Multiple published microarray data sets were used to evaluate our previously identified lung cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Ferroptosis and cancer prognosis
• Share to Gene expression and cancer classification
• Share to Lung Cancer Treatments and Mutations